Soleno Therapeutics (SLNO) had the highest return between July 1, 2023 and January 31, 2024 by a mid-cap US stock, returning 1,006.2%.
Soleno Therapeutics (SLNO) had the highest return between July 1, 2023 and January 31, 2024 by a mid-cap US stock, returning 1,006.2%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.